Related Experiment Video

Updated: Jun 13, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Combination stem cell therapy for heart failure

Thomas E Ichim1, Fabio Solano, Fabian Lara

  • 1Medistem Inc, San Diego, USA. thomas.ichim@gmail.com

International Archives of Medicine
|April 20, 2010
PubMed

Insights

Stem cell therapy offers moderate benefits for congestive heart failure (CHF) patients ineligible for transplantation. Optimization strategies include enhancing stem cell migration, activity, and combining therapies for improved outcomes.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Congestive heart failure (CHF) patients not eligible for transplantation have limited treatment options.
  • Stem cell therapy, including autologous bone marrow and mobilized peripheral blood, has been clinically applied since 2001.
  • Over 1000 patients have received cellular therapy in randomized trials, showing moderate, statistically significant benefits.

Purpose of the Study:

  • To discuss optimization strategies for stem cell therapy in congestive heart failure.
  • To explore methods for increasing stem cell migration to the heart.
  • To investigate augmenting stem cell activity and combining therapies to create a therapeutic niche.

Main Methods:

  • Review of existing stem cell therapy approaches for congestive heart failure.
  • Discussion of strategies to enhance stem cell efficacy.
  • Presentation of a case report detailing a combination stem cell protocol.

Main Results:

  • Stem cell therapy demonstrates a moderate but statistically significant benefit in congestive heart failure patients.
  • Optimization is a crucial next step in advancing this therapeutic approach.
  • A combination protocol using cord blood CD34 cells and mesenchymal-like stem cells was applied.

Conclusions:

  • Optimizing stem cell therapy is essential for improving outcomes in congestive heart failure.
  • Strategies include enhancing stem cell migration and activity, and combining cell types.
  • A case report illustrates the potential of a combined stem cell approach.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.